144 related articles for article (PubMed ID: 33206696)
1. Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.
Papaluca T; Craigie A; McDonald L; Edwards A; MacIsaac M; Holmes JA; Jarman M; Lee T; Huang H; Chan A; Lai M; Sundararajan V; Doyle JS; Hellard M; Stoove M; Howell J; Desmond P; Iser D; Thompson AJ
PLoS One; 2020; 15(11):e0242101. PubMed ID: 33206696
[TBL] [Abstract][Full Text] [Related]
2. Performance of simple serum-based tests to exclude cirrhosis prior to hepatitis C treatment in non-hospital settings in Australia.
Burrage L; Zimmerman H; Higgins S; Param K; Orme C; Mitchell J; O'Beirne J
Intern Med J; 2021 Apr; 51(4):533-539. PubMed ID: 31994285
[TBL] [Abstract][Full Text] [Related]
3. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
4. Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.
Kelly ML; Riordan SM; Bopage R; Lloyd AR; Post JJ
PLoS One; 2018; 13(2):e0192763. PubMed ID: 29438397
[TBL] [Abstract][Full Text] [Related]
5. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.
Gara N; Zhao X; Kleiner DE; Liang TJ; Hoofnagle JH; Ghany MG
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):303-8.e1. PubMed ID: 23142332
[TBL] [Abstract][Full Text] [Related]
6. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore.
Zhao Y; Thurairajah PH; Kumar R; Tan J; Teo EK; Hsiang JC
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):143-148. PubMed ID: 30558838
[TBL] [Abstract][Full Text] [Related]
7. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection.
Suan MAM; Chan HK; Sem X; Shilton S; Hassan MRA
Sci Rep; 2022 Nov; 12(1):20153. PubMed ID: 36418369
[TBL] [Abstract][Full Text] [Related]
9. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
10. Aminotransferase-to-platelet ratio index and Fibrosis-4 index score predict hepatic fibrosis evaluated by transient hepatic elastography in hepatitis C virus-infected hemodialysis patients.
Pestana NF; Equi CMA; Gomes CP; Cardoso AC; Zumack JP; Villela-Nogueira CA; Perez RM
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e260-e265. PubMed ID: 33405422
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
[TBL] [Abstract][Full Text] [Related]
12. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
[TBL] [Abstract][Full Text] [Related]
14. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
[TBL] [Abstract][Full Text] [Related]
15. The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
Lee JJ; Wei YJ; Lin MY; Niu SW; Hsu PY; Huang JC; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Huang CF; Chiu YW; Chuang WL; Yu ML
PLoS One; 2020; 15(11):e0242601. PubMed ID: 33216807
[TBL] [Abstract][Full Text] [Related]
16. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
[TBL] [Abstract][Full Text] [Related]
17. Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Jul; 8(28):45768-45776. PubMed ID: 28514753
[TBL] [Abstract][Full Text] [Related]
18. Comparing various cut-offs of aspartate aminotransferase-to-platelet ratio index (APRI) in liver cirrhosis diagnosis among hepatitis C patients in Malaysia.
Mohd Suan MA; Chan HK; Sem XH; Shilton S; Abu Hassan MR
Med J Malaysia; 2021 Nov; 76(6):828-832. PubMed ID: 34806668
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
20. Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection.
Merchante N; Mena Á; Pascasio JM; Marco A; Rodriguez M; Hernandez-Guerra M; Simón MA
Medicine (Baltimore); 2021 Nov; 100(46):e27838. PubMed ID: 34797315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
